Aducanumab reduces Aβ plaques in Alzheimer's disease.
Mov Disord. 2016 Nov;31(11):1631. doi: 10.1002/mds.26833. Epub 2016 Oct 14.
Mov Disord. 2016.
PMID: 27739124
Review.
No abstract available.